1.Progresses of screening for congenital heart defects in neonates
International Journal of Pediatrics 2014;41(2):120-123
Congenital heart defect is the leading cause of infant death in the world.How to detect and diagnose earlier is the research hot spot.Different screening methods for congenital heart defects include prenatal echocardiography,physical examination and pulse oximetry screening etc.This article is to describe the implementation of CHD screening methods in recent years.Pulse oximetry should be added to the screening methods in our country.
2.The Investigation and Analysis on the Status of Websites Construction in Jiangsu Hospital
Journal of Medical Informatics 2009;30(8):25-28
The paper analyzes the status of hospital websites construction in Jiangau province, which would provide useful evidence for further development. Surfing on the hospital wehaites covering both third and second class hospital in Jiangsu province, it reveals that the websites of third-class hospital are much better than the second-class ones. However, both of them have problems on contents, domain names and interactive parts. The paper suggests that we should constantly explore the methods and ways to solve those existing prob-lems, focus on strengthening informafization construction in hospital and play its advantages.
3.Progress in immunopathogenesis of Henoch-Sch(o)nlein purpura
International Journal of Pediatrics 2010;37(2):183-185
Henoch-Schnlein purpura(HSP) is a common autoimmune small vessel vasculitis that primarily affects children.Although the pathogenesis of HSP is unknown,there are tantalizing clues on the immune abnormalities mediated by IgA,which mainly affects the vessels of the skin,gastrointestinal tract and kidneys.The reasons of deposition maybe involve in the increases of serum IgA,the abnormalities of IgA-specific autoantibodies,structures and acceptors of IgA1,complements,and so on,which mediates the abnormal expressions of adhesion molecules and cytokines.
4.Matrix metalloproteinase-2(MMP-2)and MMP-9 or tissue inhibitors of metalloproteinase-2( TIMP-2) and TIMP-1 and kidney diseases
International Journal of Pediatrics 2011;38(4):416-419
Alterations in the balance between synthesis and degradation of extracellular matrix( ECM) and its remodeling may result in an accumulation of ECM molecules and lead to tubulointerstitial fibrosis and glomerulosclerosis and end-stage renal failure. The major physiologic regulators of ECM degradation in the glomerulus are matrix metalloproteinases ( MMP). Tissue inhibitors of metalloproteinase-2 and-1 (TIMP-2 and TIMP-1)are endogenous inhibitors of MMP-2 and MMP-9 respectively. The expression or activity of MMP and TIMP is different in all kinds of kidney diseases or pathophysiological processes. This article reviews the interrelationship of MMP-2, MMP-9, TIMP-1, TIMP-2 and kidney diseases.
5.Correlation study of the unplanned extubation caused by peripherally inserted central catheter in neonates with different tip postions
Chinese Journal of Practical Nursing 2017;33(9):675-678
Objective To investigate the incidence of the peripherally inserted central catheter (PICC) complications in neonates. Methods A retrospective analysis of PICC in 201 cases in our neonatal intensive care unit (NICU) from January 2015 to October 2016, who were divided into the central group and non-central group according to the position of the catheter tip. Compare unplanned extubation rate, catheter-related bloodstream infection rate, catheter indwelling time of PICC catheter and removing reasons between these two groups. Results One hundred and sixty-five cases in central group and thirty-six cases in non-central group. The unplanned extubation rate of the central group was 18.2% (30/165) while 22.2% (8/36) of non-central group, the difference wasnot statistically significant (χ2=0.315, P=0.639). The difference of the catheter-related bloodstream infection rate (P=0.471), the catheter indwelling time and removing reasons between these two groups were not statistically significant(P>0.05). Conclusions Even if the position of PICC tip is not in superior or inferior vena, it still can be used in neonatal population, but should pay attention to safe medical care.
6.Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma in the era of precision medicine:reports from the 57th American Society of Hematology annual meeting
Xiaojing HU ; Jumei SHI ; Bojie DAI
Journal of Leukemia & Lymphoma 2016;25(3):144-149
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma in the Western world,and is potentially curable with standard R-CHOP chemoimmunotherapy. We are now in an era that the heterogeneity of DLBCL is defined genetically and molecularly,and rational subset-specific therapeutic targets are guiding clinical trials.Primary mediastinal DLBCL is a unique clinicopathologic entity, and alternatives to R-CHOP may confer superior outcome. Rearrangement of the myc oncogene occurs in 10%of patients with DLBCL, and confers a very poor prognosis with standard R-CHOP, particularly when there is concomitant rearrangement of bcl-2, a condition referred to as double-hit DLBCL. A larger subset of DLBCL demonstrates overexpression of both myc and bcl-2 by immunohistochemistry. Analyze the source of cells by gene expression profile, immunohistochemistry algorithms,or a novel Lymph2Cx platform,provides prognostic information, and guides therapeutic decisions in both relapsed and de novo disease. This article reviews latest research presented at the 57th American Society of Hematology (ASH) annual meeting on the definition of specific subsets of DLBCL and selection of subtype-specific treatment,including novel approaches under investigation. Understanding these key features of the pathology report, and limitations of these assays defining subsets of DLBCL, allows for a precision medicine approach to this disease.
7.The hemophilias and their clinical management: reports in the 55th ASH annual meeting
Xiaojing HU ; Jun HOU ; Jumei SHI
Journal of Leukemia & Lymphoma 2014;23(2):75-78
Outcomes for patients with hemophilia have improved dramatically over the past 50 years.With the increased availability of safe clotting factor concentrates,the primary focus in clinical management is now the prevention of long-term complications,most notably the debilitating hemophilic arthropathy that is associated with severe disease.Definitive evidence of improved clinical results from primary prophylaxis started in young patients-with severe hemophilia A and a minimal bleeding history is presented.Furthermore,recent studies showing benefits for initiating prophylaxis in older adolescents and adults with established joint disease are examined.lnhibitors to factor Ⅷ are the most problematic complication of factor replacement therapy.Patient-specific and treatment-related factors that contribute to the risk of inhibitor formation are discussed and controversies and clinical evidence related to approaches for tolerance induction are reviewed.Immune tolerance induction is the proven method for eradication of inhibitors.This article reviews latest research presented at the 55th ASH annual meeting on the hemophilias and their clinical management.
8.Progress in iron chelators: the report of the 53rd annual meeting of American Society of Hematology
Xiaojing HU ; Jun HOU ; Jumei SHI
Journal of Leukemia & Lymphoma 2012;21(2):73-76
Chelation therapy could remove transfusional iron burden. Three chelators are currently available, including deferoxamine, deferiprone, and deferasirox, which can be used as monotherapy or in combination.Several factors must be considered in the design of optimal and individualized chelation regimens,which include chelator availability and its properties,degree of organ-specific iron loading,ongoing transfusional iron burden, and patient preference. Comparative effectiveness trials may help to determine the ideal strategy. This article reviews latest research presented at the 53rd annual meeting of the American Society of Hematology (ASH) on the use of iron chelators.
9.Reform and Exploration of Practice Mode for Clinical Pharmacy Undergraduate in Our University
Xiaojing MAO ; Ji ZHANG ; Qin HU
China Pharmacy 2017;28(15):2146-2149
OBJECTIVE:To provide reference for improving the quality of clinical pharmacy undergraduates in our university. METHODS:Considering about the practice problems of clinical pharmacy undergraduates in our university,pilot reform was con-ducted in the First Affiliated Hospital of our university in respects of teacher arrangement,department rotation assignment,assess-ment method. RESULTS:For new practice mode,in term of teacher arrangement,when the students were practicing in clinical pharmacy department,they were taught by clinical doctors and pharmacists;teacher training should be strengthened,and a variety of teaching methods was carried out. In term of department rotation assignment,to shorten the practice time of basic pharmacy de-partment,and increase the clinical pharmacy practice department and practice time;to integrate the content of clinical medicine and clinical pharmacy practice,and select clinical medical departments equipped with clinical pharmacists to practice. In term of assess-ment method,there were 3 aspects including clinical pharmacy practice skills assessment,drug-related theory examination and ba-sic situation assessment during internship. CONCLUSIONS:The new practice mode focuses on clinical pharmacy application skills training and students practical skills assessment,contributes to cultivate students'thinking of rational drug use and improves clini-cal practice skill of students. It is suitable for clinical pharmacy undergraduate internship of our university.
10.Study on Transdermal Penetration of Loratadine Inclusion Complexes Gels in Vitro
Ying HU ; Xinshu CHEN ; Xiaojing XIA
China Pharmacy 2007;0(29):-
0.05).The value of J of negative group was(6.180?0.214) ?g?cm-2?h-1,while there was significant difference between trial group and negative group(P